Chemomab Therapeutics News

Express News | Chemomab Therapeutics Ltd Files for Resale of up to 8.1 Mln Adss by the Selling Shareholders - SEC Filing

ReutersAug 23 16:09 ET

Chemomab Therapeutics (CMMB) Gets a Buy From Oppenheimer

TipRanksAug 22 07:15 ET · Ratings

Express News | Chemomab Says Existing Liquidity Resources Of $12.8M As Of June 30, 2024, Together With The Additional Funds Of Approximately $10M Raised In July 2024, Will Enable The Company To Fund Its Operations Through The Beginning Of 2026

BenzingaAug 21 07:09 ET

Express News | Chemomab Therapeutics Q2 2024 GAAP EPS $(0.01), Inline

BenzingaAug 21 07:07 ET

Express News | Chemomab Therapeutics: Qtrly Shr Loss of About $0.01

ReutersAug 21 07:02 ET

Express News | Chemomab Therapeutics: Completed Pipe Financing Including Major New & Existing Investors That Extends Cash Runway Through Beginning of 2026

ReutersAug 21 07:02 ET

Express News | Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

ReutersAug 21 07:00 ET

Chemomab Therapeutics 2Q Net $3.63M >CMMB

Dow JonesAug 21 07:00 ET

Chemomab Therapeutics 2Q EPS 1.3c >CMMB

Dow JonesAug 21 07:00 ET

Express News | Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update

ReutersAug 12 07:00 ET

Chemomab Therapeutics Announces Closing of $10 Million Private Placement

GlobeNewswireJul 30 09:00 ET

Roth MKM Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsJul 26 08:31 ET · Ratings

Express News | Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

ReutersJul 26 07:00 ET

ADRs Close Lower; Chemomab Therapeutics Ltd. Declines 16%

Dow JonesJul 25 16:30 ET

Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsJul 25 15:32 ET · Ratings

Chemomab Therapeutics to Raise $10 Million From Private Placement; Shares Fall

MT NewswiresJul 25 14:04 ET

Express News | Chemomab Therapeutics: Purchase Agreement Post Which Agreed to Sell in Lieu of Adss, Pre-Funded Warrants to Purchase up to 3.1 Mln Adss

ReutersJul 25 08:14 ET

Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementJul 25 08:13 ET · Announcements

Express News | Chemomab Therapeutics: Purchase Agreement With Purchasers, Post Which Co Agreed to Sell 4.2 Mln Adss

ReutersJul 25 08:12 ET

Express News | Chemomab Therapeutics Reported Topline Results From The Phase 2 SPRING Trial Of CM-101 For Primary Sclerosing Cholangitis, Achieving Its Primary Endpoint Demonstrating Anti-fibrotic, Anti-inflammatory And Anti-cholestatic Effects

BenzingaJul 25 07:45 ET